RA Capital Management’s Amylyx Pharmaceuticals AMLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$125M Buy
+4,279,341
New +$113M 1.25% 20

Other funds holding AMLX

RA Capital Management's AMLX Position: Q3 2026 in Review

RA Capital Management opened a new position in Amylyx Pharmaceuticals (AMLX) in Q3 2026: 4,279,341 shares worth $125M. The stake represents 1.25% of the portfolio and ranks #20 among its holdings.

217 funds tracked by Wall St. Rank hold AMLX as of Q3 2026.

  • RA Capital Management held 4,279,341 shares of Amylyx Pharmaceuticals worth $125M as of Q3 2026.
  • Amylyx Pharmaceuticals was a new RA Capital Management position in Q3 2026.
  • Amylyx Pharmaceuticals made up 1.25% of RA Capital Management's portfolio in Q3 2026, its #20 holding.
  • 217 funds tracked by Wall St. Rank held Amylyx Pharmaceuticals as of Q3 2026.

Based on RA Capital Management's 13F filing for Q3 2026, filed 16 Nov 2026.